Skip to content
10-K

Annual Report

PARDES BIOSCIENCES, INC.

0000950170-23-007860

← back to feed
Filed
Mar 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 10, 2023 61.72M sh
Shares Diluted FY 2022 · Dec 31, 2022 58.13M sh
Shares Diluted FY 2022 · Dec 31, 2021 3.8M sh
Operating Cash Flow FY 2022 · Dec 31, 2022 −$71.98M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$36.92M
Short Term Investments FY 2022 · Dec 31, 2022 $138.06M
Short Term Investments FY 2022 · Dec 31, 2021 $0
Cash And Equivalents FY 2022 · Dec 31, 2022 $59.28M
Cash And Equivalents FY 2022 · Dec 31, 2021 $268.68M
Stockholders Equity FY 2022 · Dec 31, 2022 $180.2M
Stockholders Equity FY 2022 · Dec 31, 2021 $266.29M
Stockholders Equity FY 2022 · Dec 31, 2020 −$13.01M
Current Liabilities FY 2022 · Dec 31, 2022 $20.43M
Current Liabilities FY 2022 · Dec 31, 2021 $8.97M
Total Liabilities FY 2022 · Dec 31, 2022 $20.43M
Total Liabilities FY 2022 · Dec 31, 2021 $8.97M
Current Assets FY 2022 · Dec 31, 2022 $200.4M
Current Assets FY 2022 · Dec 31, 2021 $275.26M
Total Assets FY 2022 · Dec 31, 2022 $200.62M
Total Assets FY 2022 · Dec 31, 2021 $275.26M
Eps Diluted FY 2022 · Dec 31, 2022 −$1.66
Eps Diluted FY 2022 · Dec 31, 2021 −$10.13
Eps Basic FY 2022 · Dec 31, 2022 −$1.66
Eps Basic FY 2022 · Dec 31, 2021 −$10.13
Rd Expense FY 2022 · Dec 31, 2022 $70.35M
Rd Expense FY 2022 · Dec 31, 2021 $28.15M
Net Income FY 2022 · Dec 31, 2022 −$96.63M
Net Income FY 2022 · Dec 31, 2021 −$38.52M
Revenue FY 2022 · Dec 31, 2022 $0